Dr Adrian Mark Salazar, DO in Leawood, KS - Medicare Pain Management

Dr Adrian Mark Salazar, DO is a medicare enrolled "Pain Medicine - Pain Medicine" physician in Leawood, Kansas. He went to Kansas City University Of Med & Biosciences, College Of Osteo Med and graduated in 2012 and has 12 years of diverse experience with area of expertise as Pain Management. He is a member of the group practice Ascentist Physicians Group Llc, Ascentist Physicians Group Llc and his current practice location is 4901 College Blvd, Leawood, Kansas. You can reach out to his office (for appointments etc.) via phone at (913) 491-3999.

Dr Adrian Mark Salazar is licensed to practice in Kansas (license number 0545158) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1316209364.

Contact Information

	Dr Adrian Mark Salazar, DO
	4901 College Blvd, Leawood, KS 66211-1602
	(913) 491-3999
	(913) 491-9309

Physician's Profile

Full Name	Dr Adrian Mark Salazar
Gender	Male
Speciality	Pain Management
Experience	12 Years
Location	4901 College Blvd, Leawood, Kansas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Adrian Mark Salazar attended and graduated from Kansas City University Of Med & Biosciences, College Of Osteo Med in 2012

NPI Data:

NPI Number: 1316209364
Provider Enumeration Date: 06/14/2012
Last Update Date: 06/05/2022

Medicare PECOS Information:

PECOS PAC ID: 3375949902
Enrollment ID: I20210908001037

Medical Identifiers

Medical identifiers for Dr Adrian Mark Salazar such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316209364	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	0545158 (Kansas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Doctors Hospital Llc	Leawood, KS	Hospital
Golden Valley Memorial Hospital	Clinton, MO	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Ascentist Physicians Group Llc	9335143759	107
Ascentist Physicians Group Llc	9335143759	107

News Archive

Study demonstrates that Parkinson's patients are more creative than their healthy peers

Prof. Rivka Inzelberg of Tel Aviv University's Sackler Faculty of Medicine and the Sagol Neuroscience Center at Sheba Medical Center, Tel Hashomer, documented the exceptional creativity of Parkinson's patients two years ago in a review for Behavioral Neuroscience. Since then, she has conducted the first empirical study to verify a link between Parkinson's disease and artistic inclination.

FDA authorizes first two COVID-19 serology tests

Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual's blood.

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

New genetic mutation increases risk for atrial fibrillation, heart failure in Black people

A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Adrian Mark Salazar allows following entities to bill medicare on his behalf.

Entity Name	The Headache & Pain Center Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1043279599 PECOS PAC ID: 7315850336 Enrollment ID: O20031126000548

News Archive

Study demonstrates that Parkinson's patients are more creative than their healthy peers

FDA authorizes first two COVID-19 serology tests

Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual's blood.

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

New genetic mutation increases risk for atrial fibrillation, heart failure in Black people

A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.

Entity Name	Ascentist Physicians Group Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1649206319 PECOS PAC ID: 9335143759 Enrollment ID: O20060829000434

Study demonstrates that Parkinson's patients are more creative than their healthy peers

FDA authorizes first two COVID-19 serology tests

Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual's blood.

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

New genetic mutation increases risk for atrial fibrillation, heart failure in Black people

A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Adrian Mark Salazar is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Adrian Mark Salazar, DO 4901 College Blvd, Leawood, KS 66211-1602 Ph: (816) 478-4200	Dr Adrian Mark Salazar, DO 4901 College Blvd, Leawood, KS 66211-1602 Ph: (913) 491-3999

News Archive

Study demonstrates that Parkinson's patients are more creative than their healthy peers

FDA authorizes first two COVID-19 serology tests

Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual's blood.

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

New genetic mutation increases risk for atrial fibrillation, heart failure in Black people

A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.

Dr Adrian Mark Salazar, DO - Medicare Pain Management in Leawood, KS

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Study demonstrates that Parkinson's patients are more creative than their healthy peers

FDA authorizes first two COVID-19 serology tests

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

New genetic mutation increases risk for atrial fibrillation, heart failure in Black people

Medicare Reassignments

Study demonstrates that Parkinson's patients are more creative than their healthy peers

FDA authorizes first two COVID-19 serology tests

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

New genetic mutation increases risk for atrial fibrillation, heart failure in Black people

Study demonstrates that Parkinson's patients are more creative than their healthy peers

FDA authorizes first two COVID-19 serology tests

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

New genetic mutation increases risk for atrial fibrillation, heart failure in Black people

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study demonstrates that Parkinson's patients are more creative than their healthy peers

FDA authorizes first two COVID-19 serology tests

MicroRNA-145 gene therapy can drastically reduce severity and progression of atherosclerosis

New genetic mutation increases risk for atrial fibrillation, heart failure in Black people

Pain Medicine Doctors in Leawood, KS